tiprankstipranks
Trending News
More News >
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
US Market

Anbio Biotechnology Class A (NNNN) Income Statement

Compare
5 Followers

Anbio Biotechnology Class A Income Statement

Last quarter (Q4 2024), Anbio Biotechnology Class A's total revenue was $2.53M, a decrease of -60.01% from previous quarter. In Q4, Anbio Biotechnology Class A's net income was $-1.32M. See Anbio Biotechnology Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 8.19M$ 6.71M$ 23.54M$ 4.43M
Gross Profit
$ 5.89M$ 3.36M$ 12.56M$ 2.54M
Operating Expenses
$ 3.89M$ 1.40M$ 2.37M$ 86.09K
Depreciation and Amortization
$ 0.00$ 13.04K$ 6.25K$ 0.00
EBITDA
$ 2.57M$ 2.45M$ 10.03M$ 2.54M
Operating Income
$ 2.00M$ 1.96M$ 10.20M$ 2.46M
Other Income/Expenses
$ 377.48K$ 292.78K$ -184.41K$ 79.94K
Pretax Income
$ 2.37M$ 2.25M$ 10.01M$ 2.54M
Net Income
$ 2.37M$ 2.25M$ 10.01M$ 2.54M
Per Share Metrics
Basic EPS
$ 0.06$ 0.02$ 0.07$ 0.03
Diluted EPS
$ 0.06$ 0.01$ 0.07$ 0.03
Weighted Average Shares Outstanding
42.29M 143.89M 143.89M 100.00M
Weighted Average Shares Outstanding (Diluted)
42.29M 187.78M 143.89M 100.00M
Currency in USD

Anbio Biotechnology Class A Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis